Piper Sandler Maintains Overweight on CVRx, Lowers Price Target to $12

Benzinga · 2d ago
Piper Sandler analyst Matt O'Brien maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $20 to $12.